Resources

Selected
  • Systematic reviews (SYSVAC)
  • Pregnant women
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

270 results found

2025 ∙ Awosan, W. R. Akinyosoye, F. O. Nana, D. W. Enaworu, O. R. Emokpae, B. E. Commey, N. K. Olasehinde, O. E.

Vaccine hesitancy among pregnant women in the U.S. and its implication for maternal and child health

  • Americas
  • United States of America
  • Pregnant women
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Dobritoiu, R. Pacurar, D. Vlad, R. M. Plesca, D. A.

Vertical Transmission of Hepatitis B and C-Then and Now-A Comprehensive Literature Systematic Review

  • Pregnant women
  • Newborn
  • Hepatitis B
  • Hepatitis C
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Riches, N. Henrion, M. Y. R. MacPherson, P. Hahn, C. Kachala, R. Mitchell, T. Murray, D. Mzumara, W. Nkoka, O. Price, A. J. Riches, J. Seery, A. Thom, N. Loarec, A. Lemoine, M. Ndow, G. Shimakawa, Y. Thompson, P. Morgan, C. Desai, S. Easterbrook, P. Stockdale, A. J.

Vertical transmission of hepatitis B virus in the WHO African region: a systematic review and meta-analysis

  • Africa
  • Pregnant women
  • Newborn
  • Hepatitis B
  • Efficacy/effectiveness
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Uta, M. Craina, M. Marc, F. Enatescu, I.

Assessing the Impact of COVID-19 Vaccination on Preterm Birth: A Systematic Review with Meta-Analysis

  • Pregnant women
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Gharpure, R. Chard, A. N. Cabrera Escobar, M. Zhou, W. Valleau, M. M. Yau, T. S. Bresee, J. S. Azziz-Baumgartner, E. Pallas, S. W. Lafond, K. E.

Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: A systematic review from 2012 to 2022

  • Children
  • Older adults
  • Pregnant women
  • Low and Middle Income Countries
  • Influenza
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Wang, J. Deng, Y. Wang, W.

COVID-19 vaccination during pregnancy and adverse perinatal outcomes: a systematic review and meta-analysis

  • Pregnant women
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Rahbeni, T. A. Satapathy, P. Itumalla, R. Marzo, R. R. Mugheed, K. A. L. Khatib, M. N. Gaidhane, S. Zahiruddin, Q. S. Rabaan, A. A. Alrasheed, H. A. Al-Subaie, M. F. Al Kaabil, N. A. Alissa, M. Ibrahim, Aaal Alsaif, H. A. Naser, I. H. Rustagi, S. Kukreti, N. Dziedzic, A.

COVID-19 Vaccine Hesitancy: Umbrella Review of Systematic Reviews and Meta-Analysis

  • All age groups
  • Healthcare workers
  • Pregnant women
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Ghafari, Z. Khameneh, A. Vahedi, L.

COVID19 Vaccination Considerations for Pregnant Women: A Systematic Review

  • Pregnant women
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Davies, H. G. Thorley, E. V. Al-Bahadili, R. Sutton, N. Burt, J. Hookham, L. Karampatsas, K. Lambach, P. Muñoz, F. Cutland, C. L. Omer, S. Le Doare, K.

Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review

  • Pregnant women
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Zhang, J. Lian, Z. Xue, X. Li, J. Zhu, Y. Huang, N. Xie, W.

Does HPV vaccination during periconceptional or gestational period increase the risk of adverse pregnancy outcomes?-An updated systematic review and meta-analysis based on timing of vaccination

  • All age groups
  • Pregnant women
  • Human papillomavirus (HPV)
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
Loading...